Absolute neutrophil count >= 1.5 x 10^9/L within 28 days of treatment initiation and must be independent of hematopoietic growth factor support
Absolute neutrophil count (ANC) >= 1500/uL (with/without growth factor)
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L without growth factor support, at the screening visit
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L without growth factor support
Absolute neutrophil count >= 1,500/mcL without growth factor support, =< 5 days prior to C1D1
Absolute neutrophil count (ANC) ? 1000/uL, with or without chronic granulocyte growth factor support
Absolute neutrophil count ? 500/mcL, and have not received any growth factor support for at least 4 weeks prior to screening
Absolute neutrophil counts of >= 1500/uL (without growth factor support) results within 7 days before study drug administration
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L in absence of growth factor support
Patients must have adequate organ and bone marrow function within 14 days prior to registration, as defined by: absolute neutrophil count >= 1,500/mcL, regardless of transfusion or growth factor support
Absolute neutrophil count (ANC) >= 500/ul in the absence of growth factor support unless due to compromised bone marrow production from CLL, indicated by >= 80% CLL in marrow
Absolute neutrophil >= 1,000/mcL; transfusion and/or growth factor are permitted within any timeframe
Absolute neutrophil count >= 1,000/mcL (without growth factor support)
Absolute neutrophil count >= 500/mcL (in the absence of growth factor support), within 14 days prior to treatment
Absolute neutrophil count >= 1,500/mcL, regardless of transfusion or growth factor support
Absolute neutrophil count (ANC) >= 0.5 x 10^9/L without daily use of myeloid growth factor
PHASE I: Absolute neutrophil count >= 1,500/mcL without growth factor support
PHASE II SCLC: Absolute neutrophil count >= 1,500/mcL without growth factor support
UROTHELIAL CARCINOMA EXPANSION COHORT: Absolute neutrophil count >= 1,500/mcL without growth factor support
mCRPC EXPANSION COHORT: Absolute neutrophil count >= 1,500/mcL without growth factor support
Absolute neutrophil count (ANC) >= 1,000/mcL with no growth factor support in the previous 3 weeks
Absolute neutrophil count (ANC) >= 1,500 cells/ul without growth factor support
Absolute neutrophil count >= 1.0 x 10^9 cells/L (growth factor use is allowed)
Absolute neutrophil count >= 1,200/mcL (without growth factor support)
Absolute neutrophil count >= 1.0 K/mcL, without use of growth factor support for 1 week
Obtained =< 14 days prior to registration: Absolute neutrophil count (ANC) >= 1000/uL (without growth factor support)
Received growth factor support or transfusions to achieve hematology entry criteria (platelets, hemoglobin, absolute neutrophil count)
Absolute neutrophil count (ANC) >/= 1,500 cells/ul without growth factor support prior to initial treatment
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L without growth factor support
Evidence of myeloid engraftment (eg, absolute neutrophil count ? 0.5 × 10^9/L for 3 consecutive days if ablative therapy was previously used). Use of growth factor supplementation is allowed.
Absolute neutrophil count (ANC) >= 1500/ul (without growth factor support)
Within 56 days prior to randomization: Absolute neutrophil count (ANC) >= 500 cells/mcL (0.5 x 10^9/L); hence ANC must be >= 500/mcL without myeloid growth factor support
Absolute neutrophil count (ANC) ? 0.75 x 10^3/uL without treatment with a myeloid growth factor within 3 days prior to first dose of IP
Absolute neutrophil count (ANC) >= 1.2 x 10^9/L without growth factor support
Absolute Neutrophil Count (ANC) ? 1.5 x 109/L without growth factor support for 7 days (14 days if received pegfilgrastim).
Absolute neutrophil count (ANC) ? 0.75 x 10^9/L in the absence of growth factor in the prior 7 days
Absolute neutrophil count (ANC) >= 1.0 x 10^9 /L, independent of growth factor support unless with bone marrow involvement for 14 days
Absolute neutrophil count >= 1,500/mcL without growth-factor support during the past month
Absolute neutrophil count >= 1.0 x 10^9 cells/L (growth factor use is allowed)
Absolute neutrophil count (ANC) > 0.75 x 10^9/L in the absence of growth factor in the prior 7 days
At least 4 weeks (28 days) prior to registration: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L without growth factor support
Absolute neutrophil count (ANC) >= 1.0 × 10^9/L (without transfusion support and without hematological growth factor support within 2 weeks of cycle 1 day 1)
Absolute neutrophil count (ANC) >= 1.0 x 10^9 /L. No transfusion or growth factor support for one week prior to labs.
Absolute neutrophil count >= 1,000/mcL in the absence of growth factor administration
Absolute neutrophil count (ANC) >= 1500/ul (without growth factor support)
Neutrophils < 1.0 x 10^9/L (neutrophil count should be > 1000 without growth factor support, unless neutropenia is caused by anti-neutrophil antibodies or other manifestation of chronic GVHD)
Absolute neutrophil count (ANC) equal or greater to 1000 without growth factor support for at least 5 days
Absolute neutrophil count >= 1,500/mcL*\r\n* Participants may be receiving growth factor support to meet these criteria
Absolute neutrophil count >= 1.0 K/uL (growth factor support is permissible)
Absolute Neutrophil count (ANC) ? 1.0 x 109/L without daily use of myeloid growth factor; and
Absolute neutrophil count >= 1,000/mcL independent of growth factor support
Absolute neutrophil count >= 1.0 x 10^9/L (without growth factor support)
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L (growth factor support is allowed to reach this goal)
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L without growth factor support
Absolute neutrophil count (ANC) >= 500/ul without growth factor or transfusional support
Absolute neutrophil count (ANC) >= 1000/ul without growth factor or transfusional support
Subjects must have the following laboratory values: Absolute Neutrophil Count (ANC) ? 1.5 x 109/L without growth factor support for 7 days (14 days if subject received pegfilgrastim).
Absolute neutrophil count (ANC) >= 1.5 X 10^9/L without (w/o) myeloid growth factor support for 7 days preceding lab assessment, obtained within 14 days prior to PET scan
Absolute neutrophil count (ANC) ?1.5 x 109/L (in absence of growth factor support)